Proteon Therapeutics

VASCULAR THERAPIES

This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.

Pathalys Pharma

This biopharmaceutical company develops treatments for secondary hyperparathyroidism in patients with end-stage kidney disease undergoing dialysis.

Healionics

Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.

ENDOVASCULAR DEVICES

This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.

CuroTis

This biotechnology company develops regenerative grafts that stimulate the body to grow patient-specific blood vessels for individuals requiring vascular access or organ regeneration.

VenoStent

This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.

Sanifit

This biopharmaceutical company develops treatments for progressive vascular calcification disorders in patients with end-stage kidney disease.

XS Innovations

This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.